15 unknown. 15 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 15 | Unknown 15 |
Follow Acute Ischemic Stroke: new trials by email Literature Review of Acute Ischemic Stroke trials Research Report on Acute Ischemic Stroke
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| High-Dose Atorvastatin for Vascular Wall Protection in Thrombectomy Patients Atorvastatin 80mg, Atorvastatin 20mg - Mechanical Thrombectomy, Acute Ischemic Stroke | Phase 4 | Unknown | Zhongda Hospital | 162 | 2023-07-01 | 2023-06-23 |
| CERebrolysine Effect on Blood-brain Barrier in acUte Ischemic Stroke Cerebrolysin - Acute Ischemic Stroke | Phase 4 | Unknown | Poznan University of Medical Sciences | 350 | 2023-01-10 | 2023-10-13 |
| Prophylactic Effects of Agomelatine for Poststroke Depression Agomelatine, Placebo Tablets - Depression, Acute Ischemic Stroke | Phase 4 | Unknown | First Affiliated Hospital, Sun Yat-Sen University | 420 | 2022-10-01 | 2022-07-27 |
| Intravenous TNK vs TPA for AIS Treatment on MSU,a Prospective Multicenter RCT tenecteplase - Intravenous, Thrombosis | Phase 4 | Unknown | Mahidol University | 160 | 2022-08-03 | 2024-07-12 |
| Treatment of Acute Ischemic Stroke With Rt-PA Combined With Edaravone Dexborneol Edaravone dexborneol - Acute Ischemic Stroke | Phase 4 | Unknown | The Second Hospital of Hebei Medical University | 400 | 2021-06-01 | 2024-02-08 |
| Hemodynamic Optimization of Cerebral Perfusion After Endovascular Therapy in Patients With Acute Ischemic Stroke Adjusted medication - Acute Ischemic Stroke | Phase 4 | Unknown | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 814 | 2021-06-01 | 2023-03-16 |
| Evaluation of Xueshuantong in Patients With AcutE IschemiC STroke Xueshuantong lyophilized powder, Placebo, Guidelines-based standard care - Acute Ischemic Stroke | Phase 4 | Unknown | Dongzhimen Hospital, Beijing | 480 | 2020-09-29 | 2021-04-09 |
| Xingnaojing for Mild-to-severe Acute Ischemic Stroke Xingnaojing injection, Xingnaojing placebo injection, Standard care - Acute Ischemic Stroke, Stroke, Acute | Phase 4 | Unknown | Dongzhimen Hospital, Beijing | 1200 | 2020-03-19 | 2021-04-01 |
| TCD Monitoring Technology Guides the Precise Control of Blood Pressure After EVT Urapidil Hydrochloride Injection - Acute Ischemic Stroke | Phase 4 | Unknown | Xuanwu Hospital, Beijing | 90 | 2018-04-08 | 2018-05-18 |
| Study on the Effectiveness and Safety of Shuxinin Injection in the Treatment of Acute Ischemic Stroke Shuxinin injection, Basic treatment, Placebo - Acute Ischemic Stroke | Phase 4 | Unknown | Peking University Third Hospital | 480 | 2018-04-01 | 2021-07-07 |
| Xingnaojing for Moderate-to-severe Acute Ischemic Stroke (XMAS) Xingnaojing injection, Standard care - Acute Ischemic Stroke | Phase 4 | Unknown | Dongzhimen Hospital, Beijing | 720 | 2016-03-01 | 2019-10-04 |
| Safety Study of Melatonin in Stroke Patients Melatonin, placebo - Acute Ischemic Stroke | Phase 4 | Unknown | Wolfson Medical Center | 140 | 2013-07-01 | 2013-05-27 |
| Safety and Efficacy of Heparin and Nadroparin in the Acute Phase of Ischemic Stroke Heparin, Nadroparin, Placebo - Acute Ischemic Stroke | Phase 4 | Unknown | University Hospital, Martin | 150 | 2013-05-01 | 2013-08-15 |
| Valsartan Efficacy on Modest Blood Pressure Reduction in Acute Ischemic Stroke Diovan® (valsartan) - Acute Ischemic Stroke | Phase 4 | Unknown | Hallym University Medical Center | 578 | 2008-10-01 | 2011-10-05 |
| Comparison of Two Strategies for Glycemic Control in Acute Ischemic Stroke Carbohydrate restrictive strategy, Intensive insulin therapy - Acute Ischemic Stroke | Phase 4 | Unknown | Hospital Sao Domingos | 70 | 2007-06-01 | 2008-09-09 |
Ischemic Stroke (15) · Stroke (2) · Death (1) · Depression (1) · Thrombosis (1)
Brain Diseases (15) · Cardiovascular Diseases (15) · Central Nervous System Diseases (15) · Cerebrovascular Disorders (15) · Nervous System Diseases (15) · Vascular Diseases (15) · Stroke (13) · Behavior (1) · Behavioral Symptoms (1) · Embolism and Thrombosis (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Standard of Care (2) · urapidil (2) · xingnaojing (2) · Atorvastatin (1) · Diltiazem (1) · Heparin (1) · Injections (1) · Labetalol (1) · Melatonin (1) · Nadroparin (1) · Nitroprusside (1) · Phenylephrine (1) · Placebo Effect (1) · Plasmalyte A (1) · Receptors, Tumor Necrosis Factor, Type I (1)
Dongzhimen Hospital, Beijing (3) · First Affiliated Hospital, Sun Yat-Sen University (1) · Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (1) · Hallym University Medical Center (1) · Hospital Sao Domingos (1) · Mahidol University (1) · Peking University Third Hospital (1) · Poznan University of Medical Sciences (1) · The Second Hospital of Hebei Medical University (1) · University Hospital, Martin (1) · Wolfson Medical Center (1) · Xuanwu Hospital, Beijing (1) · Zhongda Hospital (1)
China (7) · Brazil (1) · Israel (1) · Poland (1) · Slovakia (1) · South Korea (1) · Spain (1) · Thailand (1)
Ying Gao, MD (2) · Byung-chul Lee, MD, PhD (1) · Egon Kurca, MD, PhD, prof (1) · Gao-Jun Teng, M.D. (1) · Guojun Tan, Dr (1) · Hai-Peng Wang, M.D. (1) · Jinsheng Zeng (1) · Slawomir Michalak, Prof. (1) · Vladimir Nosal, MD, PhD (1) · Xiaogang Li (1) · Ying Gao (1)
PMID 18815396, PMID 20185783, PMID 22435369, PMID 24957314, PMID 25726502, PMID 27646496, PMID 28780236, PMID 29651371, PMID 30602354, PMID 33272127, PMID 33588587, PMID 39208776, PMID 42258192